ARQT - Arcutis Biotherapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARQT is currently covered by 8 analysts with an average price target of $35.93. This is a potential upside of $12.37 (52.5%) from yesterday's end of day stock price of $23.56.

Arcutis Biotherapeutics 's activity chart (see below) currently has 117 price targets and 133 ratings on display. The stock rating distribution of ARQT is 92.31% BUY and 7.69% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.01% with an average time for these price targets to be met of 116.5 days.

Highest price target for ARQT is $36, Lowest price target is $29, average price target is $33.71.

Most recent stock forecast was given by UY EAR from MIZUHO on 02-Mar-2026. First documented stock forecast 25-Feb-2020.

Currently out of the existing stock ratings of ARQT, 24 are a BUY (92.31%), 2 are a HOLD (7.69%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Jan-2024

$35

$13.78 (64.94%)

$37

30 days ago
(02-Mar-2026)

11/28 (39.29%)

$10.24 (41.36%)

329

Buy Since 25-Feb-2020

$35

$13.78 (64.94%)

1 months 5 days ago
(27-Feb-2026)

1/2 (50%)

$8.03 (29.77%)

27

Buy Since 07-Aug-2025

$35

$13.78 (64.94%)

$30

1 months 6 days ago
(26-Feb-2026)

2/3 (66.67%)

$6.43 (22.51%)

55

Buy Since 07-Sep-2022

$36

$14.78 (69.65%)

$31

1 months 6 days ago
(26-Feb-2026)

19/23 (82.61%)

$7.43 (26.01%)

446

Buy Since 30-Dec-2024

$34

$12.78 (60.23%)

$30

1 months 6 days ago
(26-Feb-2026)

8/9 (88.89%)

$5.43 (19.01%)

160

Show more analysts

Please expand the browser size to see the chart

What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?

On average it took 116.5 days on average for the stock forecasts to be realized with a an average price target met ratio 43.01

Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?

KEN CACCIATORE

Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?

Ken Cacciatore has 3 price targets and 2 ratings on ARQT

Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh with highest potential upside - $33.78

Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?

Nigel Dally with lowest potential downside - -$11.22

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?